Company news
ReproCELL Inc. news in 2025
ReproCELL Inc.'s news releases, calls and decks from 2025, newest first.
ReproCELL Incorporated Announces the Commercial Launch of its StemEdit Hypoimmune hiPSC Lines Generated with Advanced Gene Editing Innovations
November 7, 2025
ReproCELL: How Human Tissue Testing Adds Commercial Value for Shareholders
September 3, 2025
Current Landscape of FDA Stem Cell Approvals and Trials 2023-2025
September 2, 2025
ReproCELL Incorporated Launches ReproRegistry to Strengthen Access to Human Skin Samples for Research
August 21, 2025
ReproCELL Incorporated Unveils Cutting-Edge Neoantigen Detection Service to Propel Precision Cancer Immunotherapy
August 20, 2025